EFFECT OF A LOW-DOSE ORAL-CONTRACEPTIVE ON SERUM TESTOSTERONE LEVELS IN POLYCYSTIC OVARY DISEASE
- 1 January 1979
- journal article
- research article
- Vol. 53 (6) , 694
Abstract
A study was designed to determine the effect of a low-estrogen-dosage oral contraceptive on the serum concentration of testosterone-binding globulin (TBG) and total and unbound testosterone in patients with polycystic ovary disease. Treatment with norethindrone 0.5 mg and ethinyl estradiol 0.035 mg (Modicon) increased the TBG concentration and reduced the unbound serum testosterone concentration.This publication has 6 references indexed in Scilit:
- Oral contraceptives and nonfatal myocardial infarctionJAMA, 1978
- Comparative Studies of the Ethynyl Estrogens Used in Oral Contraceptives: Effects with and Without Progestational Agents on Plasma Androstenedione, Testosterone, and Testosterone Binding in Humans, Baboons, and BeaglesFertility and Sterility, 1978
- DIAGNOSTIC VALUE OF ANDROGEN MEASUREMENTS IN POLYCYSTIC OVARY SYNDROME1978
- Free testosterone concentration in serum: Elevation is the hallmark of hirsutismAmerican Journal of Obstetrics and Gynecology, 1977
- Testosterone-Binding Levels in the Serum of Women During the Normal Menstrual Cycle, Pregnancy, and the Post-partum PeriodJournal of Clinical Endocrinology & Metabolism, 1967
- Inactivity in vivo of Transcortin-Bound CortisolScience, 1962